Juno Therapeutics, Thermo Fisher ink partnership deal to manufacture CAR-T therapies

21st December 2017 Uncategorised 0

Juno Therapeutics, a biopharma focused on developing cellular immunotherapies to treat cancer, has inked a deal to use Thermo Fisher Scientific’s activation reagents in manufacturing its CAR-T therapies.

More: Juno Therapeutics, Thermo Fisher ink partnership deal to manufacture CAR-T therapies
Source: fierce